A retrospective analysis of patients given recombinant tissue plasminogen activator (rtPA) to treat mild stroke found that while mortality was low, approximately 30 percent could not move about without help or go directly home.

The 2015 International Stroke Conference announced its lineup of late-breaking clinical trials. The conference runs Feb. 11-13 in Nashville, Tenn.

To celebrate 50 years of research, the British Heart Foundation held a photography competition, showcasing biological imaging. The top prize and five finalists were announced Jan. 27. 

Heavy may be the head after a hard night of drinking, but research suggests that heavy drinking may also increase stroke risk in middle age, potentially leading to a stroke years earlier than familial or other risk factors may suggest.

A first-in-man study of an endovascular treatment for aortic arch aneurysms showed the less invasive approach was feasible and safe, results presented Jan. 27 at the Society of Thoracic Surgeons (STS) annual meeting in San Diego showed.

The rate of lower limb amputations in Medicare patients with peripheral artery disease (PAD) took a nosedive over the past 15 years while endovascular interventions rose, according to a study published in the January issue of JAMA Surgery.

Stroke risks after an atrial fibrillation diagnosis may be lower than previously thought. The finding, published Jan. 27 in the Journal of the American College of Cardiology, has prompted a call to reassess oral anticoagulation among these patients.

Carotid artery stenting (CAS) may benefit patients by reducing stroke risks in the long term, but recent data suggest that they may not be living long enough for that benefit to bear fruit. According to a study published online Jan. 12 in JAMA Neurology, 32 percent of elderly CAS patients died within two years of the procedure.